We came across a bullish thesis on Kenvue Inc. on Danny’s Substack by Danny Green. In this article, we will summarize the bulls’ thesis on KVUE. Kenvue Inc.’s share was trading at $18.66 as of February 19th. KVUE’s trailing and forward P/E were 24.93 and 17.01, respectively according to Yahoo Finance.
Niloo / Shutterstock.com
Kenvue, the newly independent consumer health company spun out from Johnson & Johnson, operates a portfolio of category-leading brands such as Tylenol,...
